Intermolecular Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
90
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$61.9M
- Investors
-
1
Intermolecular General Information
Description
Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support materials for the semiconductor industry. Its HPC platform, which consists of the Tempus processing tools, automated characterization methods and Informatics analysis software, is purpose-built for research and development ("R&D") using combinatorial process systems in concert with established CVD, physical vapor deposition ("PVD") and atomic layer deposition ("ALD") deposition methods. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies primarily in the Asia-Pacific region.
Contact Information
Website
www.intermolecular.comCorporate Office
- 3011 North First Street
- San Jose, CA 95134
- United States
Corporate Office
- 3011 North First Street
- San Jose, CA 95134
- United States
Intermolecular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 20-Sep-2019 | $61.9M | Completed | Generating Revenue | ||
| 6. Grant | 31-Dec-2015 | Completed | Generating Revenue | |||
| 5. IPO | 18-Nov-2011 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 07-Jan-2009 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 20-Sep-2006 | Completed | Product Development | |||
| 2. Early Stage VC (Series B) | 02-Jun-2005 | $10.1M | $10.9M | Completed | Product Development | |
| 1. Early Stage VC (Series A) | 30-Nov-2004 | $800K | $800K | Completed | Product Development |
Intermolecular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 22,780,964 | $0.001000 | $0.04 | $0.44 | $0.44 | 1x | $0.44 | 27.91% |
| Series A | 8,399,831 | $0.001000 | $0.01 | $0.1 | $0.1 | 1x | $0.1 | 10.29% |
Intermolecular Comparisons
Industry
Financing
Details
Intermolecular Competitors (7)
One of Intermolecular’s 7 competitors is MagnaChip Semiconductor, a Formerly PE-Backed company based in Cheongju, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MagnaChip Semiconductor | Formerly PE-Backed | Cheongju, South Korea | ||||
| Beneq | Formerly VC-backed | Espoo, Finland | ||||
| IQE | Formerly VC-backed | Cardiff, United Kingdom | ||||
| Quantum Materials | Formerly Accelerator/Incubator backed | San Marcos, TX | ||||
| Crocus Nano Electronics | Formerly VC-backed | Moscow, Russia |
Intermolecular Patents
Intermolecular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260209934-A1 | Doping control in tmd (transition metal dichalcogenide) films | Pending | 28-Dec-2022 | ||
| WO-2024145255-A1 | Doping control in tmd (transition metal dichalcogenide) films | Inactive | 28-Dec-2022 | ||
| US-20250137141-A1 | Selective thermal atomic layer etching | Active | 23-Jun-2022 | ||
| EP-4515016-A1 | Pending | 26-May-2022 | |||
| US-20250297352-A1 | Oxide buffer layer to promote ti02 crystallinity and increase ti02 refractive index for optical applications | Inactive | 26-May-2022 | C23C14/0036 |
Intermolecular Signals
Intermolecular Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advanced Technology Materials | Corporation | Minority | ||
| Presidio Partners | Venture Capital | Minority | ||
| Redpoint Ventures | Venture Capital | Minority | ||
| Symyx Technologies | Corporation | Minority | ||
| U.S. Venture Partners | Venture Capital | Minority |
Intermolecular ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
14.93 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Intermolecular FAQs
-
When was Intermolecular founded?
Intermolecular was founded in 2004.
-
Where is Intermolecular headquartered?
Intermolecular is headquartered in San Jose, CA.
-
What is the size of Intermolecular?
Intermolecular has 90 total employees.
-
What industry is Intermolecular in?
Intermolecular’s primary industry is General Purpose Semiconductors.
-
Is Intermolecular a private or public company?
Intermolecular is a Private company.
-
What is the current valuation of Intermolecular?
The current valuation of Intermolecular is .
-
What is Intermolecular’s current revenue?
The current revenue for Intermolecular is .
-
How much funding has Intermolecular raised over time?
Intermolecular has raised $155M.
-
Who are Intermolecular’s investors?
Advanced Technology Materials, Presidio Partners, Redpoint Ventures, Symyx Technologies, and U.S. Venture Partners have invested in Intermolecular.
-
Who are Intermolecular’s competitors?
MagnaChip Semiconductor, Beneq, IQE, Quantum Materials, and Crocus Nano Electronics are some of the 7 competitors of Intermolecular.
-
When was Intermolecular acquired?
Intermolecular was acquired on 20-Sep-2019.
-
Who acquired Intermolecular?
Intermolecular was acquired by Merck.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process